Novavax develops vaccine candidates, but this report links the share move to a suspected case in Russia, not new company news. The watched contacts tested negative and had no symptoms, so the story does not change Novavax's outlook.
This does not show a new order, trial result, or vaccine release for Novavax. The roughly 200 people watched after contact all tested negative, and none had symptoms. The case remains suspected, so the story gives no clear change to Novavax's business outlook.
Follow Novavax Inc. (NVAX) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for NVAX